Mechanistic comparison of Emodin Purgative anthraquinone found in several plants and Reserpine based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
29
Shared Targets
24%
Jaccard Similarity
18%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Emodin and Reserpine share 29 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.242 means 24% of the combined target set is bound by both compounds. The IDF-weighted score of 0.175 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Emodin and Reserpine have in common?
Emodin and Reserpine share 29 molecular targets with a Jaccard similarity of 24%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Emodin and Reserpine be combined?
Emodin and Reserpine share 29 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Emodin or Reserpine?
Both Emodin and Reserpine have substantial PubMed research. View their individual profiles for full evidence scores.